Role of uromodulin and complement activation in the progression of kidney disease

Shen,Fei; Liu,Maojing; Pei,Fei; Yu,Li; Yang,Xiangdong

doi:10.3892/ol.2021.13090

Role of uromodulin and complement activation in the progression of kidney disease

Authors:
- Fei Shen
- Maojing Liu
- Fei Pei
- Li Yu
- Xiangdong Yang
View Affiliations

Affiliations: Department of Nephrology, Qi Lu Hospital of Shandong University, Jinan, Shandong 250012, P.R. China
Published online on: October 13, 2021 https://doi.org/10.3892/ol.2021.13090
Article Number: 829
Copyright: © Shen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Uromodulin (UMOD) is a glycoprotein that is selectively expressed on the epithelial cells of the thick ascending limb of Henle's loop and the early distal renal tubule. The present study aimed to investigate whether UMOD was associated with complement activation in patients with renal diseases. In addition, its biological function was examined in vitro. The expression levels of UMOD and complement components, including C1q, C3, C4 and C3a, and membrane attack complex (MAC) in the plasma of patients with IgA nephropathy (IgAN; n=58) and lupus nephritis (LN; n=36) were detected using ELISA, which was used to determine the association between UMOD expression and complement components. In addition, a simulated hypoxia‑reoxygenation (H/R) model was used to stimulate UMOD expression in mouse inner medullary collecting duct cells. Additionally, the association between UMOD expression and complement components C1q and C3d at the cellular level was identified using western blotting and immunofluorescence, respectively. It was revealed that the plasma UMOD concentration was significantly decreased in patients with IgAN and LN compared with in healthy controls, and the levels of C3a and MAC were significantly increased in the plasma of patients with IgAN and LN. Furthermore, the plasma levels of C1q, C3 and C4 in patients with LN, but not in patients with IgAN, were significantly decreased compared with in healthy controls. The plasma levels of UMOD were negatively correlated with the plasma C3a and MAC concentrations. However, the plasma levels of UMOD were significantly and positively correlated with the plasma C1q concentration, but not with that of C3 and C4. It was identified that UMOD expression started to increase after 1 h of simulated H/R, and continued to increase at 6 and 12 h. In addition, cells with lower UMOD expression had higher C3d expression in vitro. Collectively, the present results suggested that UMOD was associated with severe complement activation and may be involved in complement‑mediated immune protection by inhibiting complement activation in renal disease.

View Figures

View References

1	Reindl J, Gröne HJ, Wolf G and Busch M: Uromodulin-related autosomal-dominant tubulointerstitial kidney disease-pathogenetic insights based on a case. Clin Kidney J. 12:172–179. 2018. View Article : Google Scholar : PubMed/NCBI
2	Vikulova OK, Zuraeva ZT, Mikhaleva OV, Nikankina LV, Shamkhalova MS, Shestakova MV and Dedov II: Renal effects of glucagon-like peptide receptor agonists in patients with type 1 diabetes mellitus. Ter Arkh. 90:59–64. 2018.PubMed/NCBI
3	Bennett MR, Pyles O, Ma Q and Devarajan P: Preoperative levels of urinary uromodulin predict acute kidney injury after pediatric cardiopulmonary bypass surgery. Pediatr Nephrol. 33:521–526. 2018. View Article : Google Scholar : PubMed/NCBI
4	Smirnov AV, Khasun M, Kayukov IG, Galkina OV, Sipovski VG, Parastaeva MM and Bogdanova EO: Serum uromodulin as an early biomarker of tubular atrophy and interstitial fibrosis in patients with glomerulopathies. Ter Arkh. 90:41–47. 2018.PubMed/NCBI
5	Devuyst O and Pattaro C: The UMOD Locus: Insights into the pathogenesis and prognosis of kidney disease. J Am Soc Nephrol. 29:713–726. 2018. View Article : Google Scholar : PubMed/NCBI
6	Lhotta K: Uromodulin and chronic kidney disease. Kidney Blood Press Res. 33:393–398. 2010. View Article : Google Scholar : PubMed/NCBI
7	Kuśnierz-Cabala B, Gala-Błądzińska A, Mazur-Laskowska M, Dumnicka P, Sporek M, Matuszyk A, Gil K, Ceranowicz P, Walocha J, Kucharz J, et al: Serum uromodulin levels in prediction of acute kidney injury in the early phase of acute pancreatitis. Molecules. 22:222017. View Article : Google Scholar : PubMed/NCBI
8	Leiherer A, Muendlein A, Saely CH, Brandtner EM, Geiger K, Fraunberger P and Drexel H: The value of uromodulin as a new serum marker to predict decline in renal function. J Hypertens. 36:110–118. 2018. View Article : Google Scholar : PubMed/NCBI
9	Micanovic R, LaFavers K, Garimella PS, Wu XR and El-Achkar TM: Uromodulin (Tamm-Horsfall protein): Guardian of urinary and systemic homeostasis. Nephrol Dial Transplant. 35:33–43. 2020. View Article : Google Scholar : PubMed/NCBI
10	Lv L, Wang J, Gao B, Wu L, Wang F, Cui Z, He K, Zhang L, Chen M and Zhao MH: Serum uromodulin and progression of kidney disease in patients with chronic kidney disease. J Transl Med. 16:3162018. View Article : Google Scholar : PubMed/NCBI
11	Micanovic R, Khan S, Janosevic D, Lee ME, Hato T, Srour EF, Winfree S, Ghosh J, Tong Y, Rice SE, et al: Tamm-horsfall protein regulates mononuclear phagocytes in the kidney. J Am Soc Nephrol. 29:841–856. 2018. View Article : Google Scholar : PubMed/NCBI
12	Skowron B, Baranowska A, Dobrek L, Ciesielczyk K, Kaszuba-Zwoinska J, Wiecek G, Malska-Wozniak A, Strus M and Gil K: Urinary neutrophil gelatinase-associated lipocalin, kidney injury molecule-1, uromodulin, and cystatin C concentrations in an experimental rat model of ascending acute kidney injury induced by pyelonephritis. J Physiol Pharmacol. 69:625–637. 2018.PubMed/NCBI
13	Martín-Gómez MA, Eliecer C, Caba Molina M, González Oller C and García Del Moral R: Familial hyperuricaemic nephropathy: New mutation in uromodulin gen. Nefrol Engl Ed. 39:309–311. 2019.PubMed/NCBI
14	Rhodes DCJ: Human Tamm-Horsfall protein, a renal specific protein, serves as a cofactor in complement 3b degradation. PLoS One. 12:e01818572017. View Article : Google Scholar : PubMed/NCBI
15	Lane BR, Babitz SK, Vlasakova K, Wong A, Noyes SL, Boshoven W, Pam Grady P, Zimmerman C, Engerman S, Gebben M, et al: Evaluation of urinary renal biomarkers for early prediction of acute kidney injury following partial nephrectomy: A feasibility study. Eur Urol Focus. 6:1240–1247. 2020. View Article : Google Scholar : PubMed/NCBI
16	Patidar KR, Garimella PS, Macedo E, Slaven JE, Ghabril MS, Weber RE, Anderson M, Orman ES, Nephew LD, Desai AP, et al: Admission plasma uromodulin and the risk of acute kidney injury in hospitalized patients with cirrhosis: A pilot study. Am J Physiol Gastrointest Liver Physiol. 317:G447–G452. 2019. View Article : Google Scholar : PubMed/NCBI
17	Tosukhowong P, Kulpradit P, Chaiyarit S, Ungjareonwattana W, Kalpongnukul N, Ratchanon S and Thongboonkerd V: Lime powder treatment reduces urinary excretion of total protein and transferrin but increases uromodulin excretion in patients with urolithiasis. Urolithiasis. 46:257–264. 2018. View Article : Google Scholar : PubMed/NCBI
18	Gast C, Marinaki A, Arenas-Hernandez M, Campbell S, Seaby EG, Pengelly RJ, Gale DP, Connor TM, Bunyan DJ, Hodaňová K, et al: Autosomal dominant tubulointerstitial kidney disease-UMOD is the most frequent non polycystic genetic kidney disease. BMC Nephrol. 19:3012018. View Article : Google Scholar : PubMed/NCBI
19	Tokonami N, Olinger E, Debaix H, Houillier P and Devuyst O: The excretion of uromodulin is modulated by the calcium-sensing receptor. Kidney Int. 94:882–886. 2018. View Article : Google Scholar : PubMed/NCBI
20	Bullen AL, Katz R, Lee AK, Anderson CAM, Cheung AK, Garimella PS, Jotwani V, Haley WE, Ishani A, Lash JP, et al: The SPRINT trial suggests that markers of tubule cell function in the urine associate with risk of subsequent acute kidney injury while injury markers elevate after the injury. Kidney Int. 96:470–479. 2019. View Article : Google Scholar : PubMed/NCBI
21	Scherberich JE, Gruber R, Nockher WA, Christensen EI, Schmitt H, Herbst V, Block M, Kaden J and Schlumberger W: Serum uromodulin-a marker of kidney function and renal parenchymal integrity. Nephrol Dial Transplant. 33:284–295. 2018. View Article : Google Scholar : PubMed/NCBI
22	Wiromrat P, Bjornstad P, Roncal C, Pyle L, Johnson RJ, Cherney DZ, Lipina T, Bishop F, Maahs DM and Wadwa RP: Serum uromodulin is associated with urinary albumin excretion in adolescents with type 1 diabetes. J Diabetes Complications. 33:648–650. 2019. View Article : Google Scholar : PubMed/NCBI
23	Schiano G, Glaudemans B, Olinger E, Goelz N, Müller M, Loffing-Cueni D, Deschenes G, Loffing J and Devuyst O: The urinary excretion of uromodulin is regulated by the potassium channel ROMK. Sci Rep. 9:195172019. View Article : Google Scholar : PubMed/NCBI
24	Cañadas-Garre M, Anderson K, McGoldrick J, Maxwell AP and McKnight AJ: Proteomic and metabolomic approaches in the search for biomarkers in chronic kidney disease. J Proteomics. 193:93–122. 2019. View Article : Google Scholar : PubMed/NCBI
25	Graham LA, Aman A, Campbell DD, Augley J, Graham D, McBride MW, Fraser NJ, Ferreri NR, Dominiczak AF and Padmanabhan S: Salt stress in the renal tubules is linked to TAL-specific expression of uromodulin and an upregulation of heat shock genes. Physiol Genomics. 50:964–972. 2018. View Article : Google Scholar : PubMed/NCBI
26	Song H, Hu H, Tang F, Cao C, Wan Q and He Y: Initial serum creatinine concentration affects clinical outcomes in patients with IgA nephropathy treated with mycophenolate mofetil combined with low-dose prednisone. Exp Ther Med. 19:3369–3376. 2020.PubMed/NCBI
27	Hwang J, Kim HJ, Oh JM, Ahn JK, Lee YS, Lee J, Kim YG, Huh WS, Seo J, Koh EM, et al: Outcome of reclassification of World Health Organization (WHO) class III under International Society of Nephrology-Renal Pathology Society (ISN-RPS) classification: Retrospective observational study. Rheumatol Int. 32:1877–1884. 2012. View Article : Google Scholar : PubMed/NCBI
28	Chen Y, Harty GJ, Zheng Y, Iyer SR, Sugihara S, Sangaralingham SJ, Ichiki T, Grande JP, Lee HC, Wang X, et al: CRRL269. Circ Res. 124:1462–1472. 2019. View Article : Google Scholar : PubMed/NCBI
29	Bostom A, Steubl D, Garimella PS, Franceschini N, Roberts MB, Pasch A, Ix JH, Tuttle KR, Ivanova A, Shireman T, et al: Serum uromodulin: A biomarker of long-term kidney allograft failure. Am J Nephrol. 47:275–282. 2018. View Article : Google Scholar : PubMed/NCBI
30	Steubl D, Buzkova P, Ix JH, Devarajan P, Bennett MR, Chaves PH, Shlipak MG, Bansal N, Sarnak MJ and Garimella PS: Association of serum and urinary uromodulin and their correlates in older adults-The Cardiovascular Health Study. Nephrology (Carlton). 25:522–526. 2020. View Article : Google Scholar : PubMed/NCBI
31	Nie M, Bal MS, Liu J, Yang Z, Rivera C, Wu XR, Hoenderop JG, Bindels RJ, Marciano DK and Wolf MT: Uromodulin regulates renal magnesium homeostasis through the ion channel transient receptor potential melastatin 6 (TRPM6). J Biol Chem. 293:16488–16502. 2018. View Article : Google Scholar : PubMed/NCBI
32	Tokonami N, Takata T, Beyeler J, Ehrbar I, Yoshifuji A, Christensen EI, Loffing J, Devuyst O and Olinger EG: Uromodulin is expressed in the distal convoluted tubule, where it is critical for regulation of the sodium chloride cotransporter NCC. Kidney Int. 94:701–715. 2018. View Article : Google Scholar : PubMed/NCBI
33	Maydan O, McDade PG, Liu Y, Wu XR, Matsell DG and Eddy AA: Uromodulin deficiency alters tubular injury and interstitial inflammation but not fibrosis in experimental obstructive nephropathy. Physiol Rep. 6:e136542018. View Article : Google Scholar : PubMed/NCBI
34	Yamamoto CM, Murakami T, Oakes ML, Mitsuhashi M, Kelly C, Henry RR and Sharma K: Uromodulin mRNA from urinary extracellular vesicles correlate to kidney function decline in type 2 diabetes mellitus. Am J Nephrol. 47:283–291. 2018. View Article : Google Scholar : PubMed/NCBI
35	Lin Z, Yang J, Liu H, Cai D, An Z, Yu Y and Chen T: A novel uromodulin mutation in autosomal dominant tubulointerstitial kidney disease: A pedigree-based study and literature review. Ren Fail. 40:146–151. 2018. View Article : Google Scholar : PubMed/NCBI
36	Olinger E, Lake J, Sheehan S, Schiano G, Takata T, Tokonami N, Debaix H, Consolato F, Rampoldi L, Korstanje R, et al: Hepsin-mediated processing of uromodulin is crucial for salt-sensitivity and thick ascending limb homeostasis. Sci Rep. 9:122872019. View Article : Google Scholar : PubMed/NCBI
37	Bus P, Chua JS, Klessens CQF, Zandbergen M, Wolterbeek R, van Kooten C, Trouw LA, Bruijn JA and Baelde HJ: Complement activation in patients with diabetic nephropathy. Kidney Int Rep. 3:302–313. 2017. View Article : Google Scholar : PubMed/NCBI
38	Tachibana S, Iyoda M, Suzuki T, Kanazawa N, Iseri K, Wada Y, Matsumoto K and Shibata T: Serum uromodulin is associated with the severity of clinicopathological findings in ANCA-associated glomerulonephritis. PLoS One. 14:e02246902019. View Article : Google Scholar : PubMed/NCBI
39	Sjaarda J, Gerstein HC, Yusuf S, Treleaven D, Walsh M, Mann JF, Hess S and Paré G: Blood HER2 and uromodulin as causal nediators of CKD. J Am Soc Nephrol. 29:1326–1335. 2018. View Article : Google Scholar : PubMed/NCBI
40	Bjornstad P, Wiromrat P, Johnson RJ, Sippl R, Cherney DZ, Wong R, Rewers MJ and Snell-Bergeon JK: Serum uromodulin predicts less coronary artery calcification and diabetic kidney disease over 12 years in adults with type 1 diabetes: The CACTI Study. Diabetes Care. 42:297–302. 2019. View Article : Google Scholar : PubMed/NCBI
41	Wang L, Peng SW and Liu Q: The relationship between interleukin 6 and periodontitis Chinese Journal of Conservative Dentistry. 1:53–56. 2003.(In Chinese).
42	LaFavers KA, Macedo E, Garimella PS, Lima C, Khan S, Myslinski J, McClintick J, Witzmann FA, Winfree S, Phillips CL, et al: Circulating uromodulin inhibits systemic oxidative stress by inactivating the TRPM2 channel. Sci Transl Med. 11:112019. View Article : Google Scholar : PubMed/NCBI
43	Then C, Then H, Lechner A, Huth C, Meisinger C, Heier M, Peters A, Koenig W, Rathmann W, Herder C, et al: Serum uromodulin is inversely associated with the metabolic syndrome in the KORA F4 study. Endocr Connect. 8:1363–1371. 2019. View Article : Google Scholar : PubMed/NCBI
44	Wheeler E and Thomas S: Diagnosis and long-term management of uromodulin kidney disease. Cureus. 11:e42702019.PubMed/NCBI